Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
Richard Turkington(Queen's University Belfast), Patrick G. Johnston(Queen's University Belfast)
Cited by 96
Related Papers
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
|Nature Reviews Clinical Oncology|2017|241
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
|Oncogene|2001|153
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
|British Journal of Cancer|2006|125
Prognostic importance of thymidylate synthase expression in early breast cancer.
|Journal of Clinical Oncology|1997|124
Cathepsin S expression: An independent prognostic factor in glioblastoma tumours—a pilot study
|International Journal of Cancer|2006|83